PAA 4.88% 21.5¢ pharmaust limited

Mr Michael Thurn CEO Interview On Small Caps, page-56

  1. 1,267 Posts.
    lightbulb Created with Sketch. 427
    MPL is being trialed, not developed, or tested. It's the end product, just correct dose to be determined.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.